Sangamo Therapeutics

Featured

Wealthy VC’s 18-Month Winner Recap: Our Biggest Market Calls That Soared

At Wealthy VC, we don’t just watch the ticker tape; we anticipate where the next wave of momentum will strike.…

Read More »
Biotech

Sangamo Therapeutics Inks $1.95B Deal With Genentech to Target Alzheimer’s, SGMO Stock Pops 29%

In a significant advancement for the field of genomic medicine, Sangamo Therapeutics has entered a landmark license agreement with Genentech,…

Read More »
Back to top button